United States
CARDENE IV (nicardipine hydrochloride) premixed injection in 0.83% Sodium Chloride 40 mg in 200 mL (0.2 mg/mL)
Product Characteristics
| Trademark: | CARDENE is a registered trademark of EKR Therapeutics, Inc., Galaxy is a registered trademark of Baxter International Inc. |
| Latex: | Not Made with Natural Rubber Latex |
| Container Type: | GALAXY |
| PVC: | Non-PVC |
| DEHP: | Non-DEHP |
| Volume: | 200 ML |
| Dosage Form: | Liquid |
| Diluent: | Sodium Chloride |
| Strength: | 40 mg/200 mL |
| Concentration: | 0.2 mg/mL |
| Shelf Life from manufacture: | 24 months |
| Contains Preservative: | No |
| Storage Recommendations: | Store at controlled room temperature 20º to 25ºC (68º to 77ºF), refer to USP Controlled Room Temperature. Protect from freezing. Avoid excessive heat. Protect from light, store in carton until ready to use. |
| Rx Only: | Yes |
Carton
| Pack Factor: | 10 |
Reimbursement Information
| HCPCS Code | HCPCS Descriptor |
| J3490 | UNCLASSIFIED DRUGS |
| Medication Delivery Reimbursement Hotline | 888-338-0001 |
| Information Source: CMS Disclaimer: The coverage, coding, and payment information included in this guide has been compiled from various resources for informational use as a tool to assist providers with reimbursement issues. This information is current as of 3/31/2008; however this information is subject to change and should not be construed as legal advice. Providers should exercise independent clinical judgment when selecting codes and submitting claims to accurately reflect services rendered to individual patients. Baxter Healthcare Corporation does not guarantee success in obtaining insurance payments. Providers are encouraged to contact third-party payors for specific information on their coverage, coding, and payment policies. |
|
